The Asia Pacific Mobile Cardiac Telemetry Systems Market would witness market growth of 12.7% CAGR during the forecast period (2020-2026).
Mobile Cardiac Telemetry (MCT) is becoming more and more common as the device is far less labor-intensive than the traditional event monitor for the patient. A Cardiac Event Monitor is a tool used to track ONE signs felt by the patient. The MCT monitor can transmit both symptoms felt by the patient and abnormalities not felt by the patient. In addition, MCT monitoring is useful as communication is constant so that, if messages are required to be transmitted to the patient, the process is simple and reliable because it uses standard cell phone technology.
Mobile Cardiac Telemetry tracking is a wave of the future as there are too many technical benefits relative to other long-term monitoring options. The MCT monitoring technology may be considered a better tool for the identification of ECG abnormalities because it detects heart problems in real-time. The accelerated nature of MCT can potentially improve diagnostic care and reduce health care costs over the long term.
Increasing the prevalence of cardiovascular diseases and related mortality has raised an understanding of the advantages of mobile cardiac telemetry (MCT) technology and has stimulated market development. Emerging markets in developed economies are projected to be a critical driver creating more and more profitable growth prospects for global players to extend their sector and geographic reach. Most market players are focusing on emerging markets, such as the Asia Pacific, due to an increase in the prevalence of heart disease and an increase in the popularity of advanced treatment in the region.
In India, medical research has developed steadily, as have global developments in recent decades. Total occlusion treatment has been common for people from other countries moving here to seek care for themselves. The most likely and compelling reason for this could be the excessively high cost of health care in their country. Owing to current exchange rates and many other reasons, the diagnosis of heart disease in India is becoming very cheap compared to other foreign countries. In Japan, the number of foreign visitors is increasing, which will add to the growing importance of the Japanese economy.
Based on Application, the market is segmented into Lead based and Patch Based. Based on End User, the market is segmented into Hospitals, Cardiac centers and Other End-user. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Hill-Rom Holdings, Inc. (Welch Allyn), Asahi Kasei Corporation (Zoll Medical Corporation), ScottCare Corporation (Berkshire Hathway, Inc.), iRhythm Technologies, Inc., Biotricity, Inc., G Medical Innovations Holdings Ltd. (Telerhythmics LLC), BioTelemetry, Inc., Applied Cardiac Systems, Inc., Medicomp, Inc., and Preventice Solutions, Inc.
Scope of the Study
Market Segmentation:
By Application

  • Lead based and
  • Patch Based

By End User

  • Hospitals
  • Cardiac centers and
  • Other End-user

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • Hill-Rom Holdings, Inc. (Welch Allyn)
  • Asahi Kasei Corporation (Zoll Medical Corporation)
  • ScottCare Corporation (Berkshire Hathway, Inc.)
  • iRhythm Technologies, Inc.
  • Biotricity, Inc.
  • G Medical Innovations Holdings Ltd. (Telerhythmics LLC)
  • BioTelemetry, Inc.
  • Applied Cardiac Systems, Inc.
  • Medicomp, Inc.
  • Preventice Solutions, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free